Atlas Trials

SWITCH: Stentrode First-in-Human Study of Implantable BCI for Control of a Digital Device

Clinical trial NCT03834857 · COMPLETED

Trial details

NCT number
NCT03834857
Sponsor
Synchron Australia Pty Ltd.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Neurologic Disorder
Start date
2019-05-27
Primary completion
2021-12-10
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.